Miquel M - Search Results

1

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain.

Lens S, Miquel M, Mateos-Muñoz B, García-Samaniego J, Forns X. Lens S, et al. Among authors: miquel m. J Hepatol. 2020 Nov;73(5):1262-1263. doi: 10.1016/j.jhep.2020.07.007. Epub 2020 Jul 13. J Hepatol. 2020. PMID: 32673740 Free PMC article. No abstract available.

2

Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice.

Miquel M, Núñez Ó, Trapero-Marugán M, Díaz-Sánchez A, Jiménez M, Arenas J, Canós AP. Miquel M, et al. Ann Hepatol. 2013 Mar-Apr;12(2):205-12. Ann Hepatol. 2013. PMID: 23396731 Free article.

3

Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C.

Gallach M, Vergara M, Miquel M, Casas M, Sánchez-Delgado J, Dalmau B, Gil M, Rudi N, Parra I, López M, Dosal A, Moreno L, Valero O, Calvet X. Gallach M, et al. Among authors: miquel m. Ann Hepatol. 2016 Jul-Aug;15(4):524-31. Ann Hepatol. 2016. PMID: 27236151 Free article.

4

Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.

Puigvehí M, Londoño MC, Torras X, Lorente S, Vergara M, Morillas RM, Masnou H, Serrano T, Miquel M, Gallego A, Lens S, Carrión JA. Puigvehí M, et al. Among authors: miquel m. J Gastroenterol. 2020 Feb;55(2):205-216. doi: 10.1007/s00535-019-01619-0. Epub 2019 Sep 6. J Gastroenterol. 2020. PMID: 31493238

5

Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.

Mateos-Muñoz B, Buti M, Vázquez IF, Conde MH, Bernal-Monterde V, Díaz-Fontenla F, Morillas RM, García-Buey L, Badía E, Miquel M, Amador-Navarrete A, Rodríguez-Tajes S, Ramos-Merino L, Madejón A, García-Retortillo M, Arenas JI, Cabezas J, Santiago JMG, Fernández-Rodríguez C, Cordero P, Diago M, Mancebo A, Pardo A, Rodríguez M, Hoyas E, Moreno JJ, Turnes J, Simón MÁ, Marcos-Fosch C, Calleja JL, Bañares R, Lens S, Garcia-Samaniego J, Crespo J, Romero-Gomez M, Gea F, de Santiago ER, Moreno S, Albillos A. Mateos-Muñoz B, et al. Among authors: miquel m. Dig Dis Sci. 2023 Jun;68(6):2731-2737. doi: 10.1007/s10620-022-07817-w. Epub 2023 Feb 3. Dig Dis Sci. 2023. PMID: 36737575 Free PMC article.

6

Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C.

Vergara M, Bejarano G, Dalmau B, Gil M, Miquel M, Sanchez-Delgado J, Casas M, Puig J, Martinez-Bauer E, Dosal A, Lopez M, Moreno L, Valero O, Bella MR, Calvet X. Vergara M, et al. Among authors: miquel m. Eur J Gastroenterol Hepatol. 2015 Jul;27(7):826-33. doi: 10.1097/MEG.0000000000000346. Eur J Gastroenterol Hepatol. 2015. PMID: 26043289

7

Comparison of effectiveness and discontinuation of interferon-free therapy for hepatitis C in prison inmates and noninmates.

Marco A, Roget M, Cervantes M, Forné M, Planella R, Miquel M, Ortiz J, Navarro M, Gallego C, Vergara M; In and Out of Prison Study Group. Marco A, et al. Among authors: miquel m. J Viral Hepat. 2018 Nov;25(11):1280-1286. doi: 10.1111/jvh.12940. Epub 2018 Jun 28. J Viral Hepat. 2018. PMID: 29851225

8

Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization.

Sánchez-Delgado J, Vergara M, Machlab S, Lira A, Gómez Zaragoza C, Criado E, Rosinach M, Batista L, Arau B, Roget M, Ortiz J, Garcia C, Sort P, Casas M, Dalmau B, Forné M, Falcó J, Miquel M. Sánchez-Delgado J, et al. Among authors: miquel m. Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1453-1460. doi: 10.1097/MEG.0000000000001229. Eur J Gastroenterol Hepatol. 2018. PMID: 30113926

9

Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents.

Vergara M, Miquel M, Vela E, Cleries M, Pontes C, Prat A, Rué M. Vergara M, et al. Among authors: miquel m. J Viral Hepat. 2021 May;28(5):728-738. doi: 10.1111/jvh.13479. Epub 2021 Mar 11. J Viral Hepat. 2021. PMID: 33555102

10

Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites.

Montoliu S, Ballesté B, Planas R, Alvarez MA, Rivera M, Miquel M, Masnou H, Cirera I, Morillas RM, Coll S, Sala M, García-Retortillo M, Cañete N, Solà R. Montoliu S, et al. Among authors: miquel m. Clin Gastroenterol Hepatol. 2010 Jul;8(7):616-22; quiz e80. doi: 10.1016/j.cgh.2010.03.029. Epub 2010 Apr 24. Clin Gastroenterol Hepatol. 2010. PMID: 20399905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

340 results

Search Page